Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 2/20 | 0.32 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.32 |
| ▸ | CASP7 | P55210 | 2/20 | 0.32 |
| ▸ | HBB | P68871 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14865834 | 0.90 | PTGS1 (0.41) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| SCHEMBL12307300 | 0.90 | PTGS1 (0.48) | PTGS1ADORA1ABCB1USP2MEN1 | |
| SCHEMBL14865832 | 0.90 | PTGS1 (0.47) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| SCHEMBL24137892 | 0.90 | PTGS1 (0.48) | PTGS1ADORA1ABCB1USP2MEN1 | |
| SCHEMBL14865795 | 0.89 | PTGS1 (0.43) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| SCHEMBL13976307 | 0.89 | PTGS1 (0.40) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| SCHEMBL12836951 | 0.89 | PTGS1 (0.43) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| SCHEMBL13401328 | 0.88 | PTGS1 (0.43) | PTGS1ADORA1USP2MEN1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29349584 | 0.87 | PTGS1 (0.42) | PTGS1ADORA1 | |
| SCHEMBL13977982 | 0.87 | PTGS1 (0.45) | PTGS1ADORA1USP2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-20220144845-A1 | SUBSTITUTED PYRROLO[1,2-a]QUINOXALIN-4(5H)-ONES AS CX3CR1 ANTAGONISTS | UNIV DREXEL (US) | 2022-05-12 | — | — | US | disclosed |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-13 | — | — | US | disclosed |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-31 | — | — | US | disclosed |
| US-20180221500-A1 | Environmentally Sensitive Compositions and Methods of Use Thereof | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES | 2018-08-09 | — | — | US | disclosed |
| US-9855338-B2 | Polyglutamate-amino acid conjugates and methods | NITTO DENKO CORPORATION (JP) | 2018-01-02 | — | — | US | disclosed |
| US-9814781-B2 | Environmentally sensitive compositions and methods of use thereof | RHODE ISLAND COUNCIL ON POSTSECONDARY EDUCATION (STATUTORY SUCCESSOR TO RHODE ISLAND BOARD OF GOVERNORS FOR HIGHER EDUCATION) (US) | 2017-11-14 | — | — | US | disclosed |
| US-20170137628-A1 | COLOR CONVERSION IN LCD DISPLAYS | MOLECULED LTD. (IL) | 2017-05-18 | — | — | US | disclosed |
| US-20170139277-A1 | COLOR CONVERSION IN LCD DISPLAYS | MOLECULED LTD. (IL) | 2017-05-18 | — | — | US | disclosed |
| US-20170137627-A1 | COLOR CONVERSION IN LCD DISPLAYS | MOLECULED LTD. (IL) | 2017-05-18 | — | — | US | disclosed |
| US-8197828-B2 | Compositions that include a hydrophobic compound and a polyamino acid conjugate | NITTO DENKO CORPORATION (JP) | 2012-06-12 | — | — | US | disclosed |
| US-20120052015-A1 | END-CAPPED POLYMERS | NITTO DENKO CORPORATION (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20110224148-A1 | CARBOHYDRATE-POLYAMINO ACID-DRUG CONJUGATES | NITTO DENKO CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20080279778-A1 | POLYGLUTAMATE CONJUGATES AND POLYGLUTAMATE-AMINO ACID CONJUGATES HAVING A PLURALITY OF DRUGS | NITTO DENKO CORPORATION (JP) | 2008-11-13 | — | — | US | disclosed |
| US-20080279782-A1 | POLYMERS CONJUGATED WITH PLATINUM DRUGS | NITTO DENKO CORPORATION (JP) | 2008-11-13 | — | — | US | disclosed |
| US-20080279777-A1 | COMPOSITIONS THAT INCLUDE A HYDROPHOBIC COMPOUND AND A POLYAMINO ACID CONJUGATE | NITTO DENKO CORPORATION (JP) | 2008-11-13 | — | — | US | disclosed |
| US-20080253969-A1 | MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS | NITTO DENKO CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
| US-20080181852-A1 | Multi-functional Drug Carriers | NITTO DENKO CORPORATION (JP) | 2008-07-31 | — | — | US | disclosed |
| US-7304146-B2 | Fluorogenic kinase assays and substrates | APPLERA CORPORATION (US) | 2007-12-04 | — | — | US | disclosed |
| US-20070128118-A1 | POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | NITTO DENKO CORPORATION (JP) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, ST3GAL3 | PTGS1 4712/4885ADORA1 3958/4885ABCB1 2694/4885 |
| US-20080279778-A1 | POLYGLUTAMATE CONJUGATES AND POLYGLUTAMATE-AMINO ACID CONJUGATES HAVING A PLURALITY OF DRUGS | QPCT, SGTA, GLUL | PTGS1 2922/4885ADORA1 1416/4885ABCB1 345/4885 |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | PTGS1 4333/4885ADORA1 4341/4885ABCB1 4488/4885 |
| US-20080253969-A1 | MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS | CD44, SGTA, IDUA | PTGS1 3397/4885ADORA1 3460/4885ABCB1 129/4885 |
| US-20220144845-A1 | SUBSTITUTED PYRROLO[1,2-a]QUINOXALIN-4(5H)-ONES AS CX3CR1 ANTAGONISTS | CX3CR1, CCR5, CCL2 | PTGS1 337/4885ADORA1 565/4885ABCB1 736/4885 |
| US-20180221500-A1 | Environmentally Sensitive Compositions and Methods of Use Thereof | PHLPP1, PHLPP2, FABP2 | PTGS1 3438/4885ADORA1 4477/4885ABCB1 2868/4885 |
| US-20070128118-A1 | POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | FOLH1, SLC7A1, SLC3A2 | PTGS1 2428/4885ADORA1 2644/4885ABCB1 1133/4885 |
| US-20080181852-A1 | Multi-functional Drug Carriers | SLC7A1, SLC19A1, SLC43A1 | PTGS1 2340/4885ADORA1 1263/4885ABCB1 85/4885 |
| US-20120052015-A1 | END-CAPPED POLYMERS | CAPG, ECPAS, PUF60 | PTGS1 4455/4885ADORA1 3631/4885ABCB1 1199/4885 |
| US-20110224148-A1 | CARBOHYDRATE-POLYAMINO ACID-DRUG CONJUGATES | CSGALNACT1, FUT6, FUT5 | PTGS1 2233/4885ADORA1 1635/4885ABCB1 558/4885 |
| US-20080279777-A1 | COMPOSITIONS THAT INCLUDE A HYDROPHOBIC COMPOUND AND A POLYAMINO ACID CONJUGATE | SLC7A1, MSN, CD44 | PTGS1 4305/4885ADORA1 2370/4885ABCB1 329/4885 |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | FUT5, FUT6, OGT | PTGS1 4333/4885ADORA1 4341/4885ABCB1 4488/4885 |
| US-20080279782-A1 | POLYMERS CONJUGATED WITH PLATINUM DRUGS | FOLR1, PAICS, ABCC1 | PTGS1 1179/4885ADORA1 3220/4885ABCB1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.